For the 1,111 patients, the median age was 36 years (IQR: 31–42), 563 (51%) were males, median CD4 counts was 235 cells/mL (IQR: 139–366), and 393 (42%) had CD4 counts below 200 cells/ mL at TB treatment completion. This evidence concerns the gene CD4 and tuberculosis.